THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.

Excerpt The clinical benefits derived from controlling the hyperuricemia of patients with gouty arthritis have been well-established (1, 2). This has been achieved by using uricosuric drugs to incr...

[1]  Rw Rundres.  Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout , 1963 .

[2]  A. Grayzel,et al.  Suppression of uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine. , 1960, The Journal of clinical investigation.

[3]  R. Friedman,et al.  Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidase. , 1963, Biochimica et biophysica acta.

[4]  E. C. Bartels,et al.  Gout: six-year follow-up on probenecid (benemid) therapy. , 1959, Arthritis and rheumatism.

[5]  G. Hitchings,et al.  Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidase , 1963 .

[6]  A. Gutman,et al.  Mobilization of gouty tophi by protracted use of uricosuric agents. , 1951, The American journal of medicine.

[7]  A. Grayzel,et al.  Uric acid production in gout. , 1961, The Journal of clinical investigation.

[8]  A. Sjoerdsma,et al.  Enzyme Defect in a Case of Xanthinuria , 1964, Nature.

[9]  A. Gutman,et al.  EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. , 1964, The American journal of medicine.

[10]  R. Howell,et al.  THE RENAL EXCRETION OF URIC ACID IN GOUT. , 1962, The Journal of clinical investigation.

[11]  R. K. Robins,et al.  Pyrazolopyrimidines as inhibitors and substrates of xanthine oxidase. , 1957, The Journal of biological chemistry.

[12]  J. Wyngaarden,et al.  Utilization of hypoxanthine, adenine and 4-amino-5-imidazole-carboxamide for uric acid synthesis in man. , 1959, Metabolism: clinical and experimental.